Literature DB >> 19303569

Clostridium difficile is no longer just a nosocomial infection or an infection of adults.

Hanna Pituch1.   

Abstract

Clostridium difficile is the main cause of nosocomial gastrointestinal disorders. Historically, C. difficile has usually affected older patients, hospital inpatients, and long-term care facility residents. Recent reports suggest that the occurrence and severity of C. difficile-associated disease (CDAD) is increasing in populations previously considered to be at low risk of the infection, and increasing numbers of community-acquired cases of CDAD are being reported. Risk factors for CDAD in paediatric patients include disruption of the normal microflora of the gastrointestinal tract (antibiotic-associated and non-antibiotic-associated), age, immune status, diet, underlying conditions, concurrent infections, and cancer. CDAD in populations previously thought to be at low risk is an emerging problem.

Entities:  

Mesh:

Year:  2009        PMID: 19303569     DOI: 10.1016/S0924-8579(09)70016-0

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  22 in total

1.  Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection.

Authors:  Tavan Janvilisri; Joy Scaria; Yung-Fu Chang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 2.  Human microbiome: From the bathroom to the bedside.

Authors:  Stephen Malnick; Ehud Melzer
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

3.  A Novel Quantitative Sampling Technique for Detection and Monitoring of Clostridium difficile Contamination in the Clinical Environment.

Authors:  Shanom Ali; Monika Muzslay; Peter Wilson
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

4.  Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; R Guzman-Perez; V Gainer; T Cai; S Churchill; I Kohane; R M Plenge; S Murphy
Journal:  Aliment Pharmacol Ther       Date:  2012-02-23       Impact factor: 8.171

Review 5.  The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

Authors:  E R Dubberke; D B Haslam; C Lanzas; L D Bobo; C-A D Burnham; Y T Gröhn; P I Tarr
Journal:  Zoonoses Public Health       Date:  2010-09-24       Impact factor: 2.702

Review 6.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 7.  Clostridium difficile infection: epidemiology, risk factors and management.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

8.  Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions.

Authors:  V K Viswanathan; M J Mallozzi; Gayatri Vedantam
Journal:  Gut Microbes       Date:  2010-06-16

9.  Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters.

Authors:  Tanis C Dingle; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

10.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.